Evidence of Bacterial Biofilms among Infected and Hypertrophied Tonsils in Correlation with the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases

<table>Antimicrobial susceptibility of tonsillar isolates against selected non-<i>β</i>-lactam agents. AN: amikacin, AZM: azithromycin, CM: clindamycin, CIP: ciprofloxacin, SXT: co-trimoxazole, EM: erythromycin, FA: fusidic Acid, GM: gentamicin, RA: rifampin, VA: vancomycin. (S) indicates susceptible isolates and (R) indicates resistant isolates.</table>

International Journal of Otolaryngology

fig2

Figure 2

Figure 2: Evidence of Bacterial Biofilms among Infected and Hypertrophied Tonsils in Correlation with the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases 

Figure 2 | Evidence of Bacterial Biofilms among Infected and Hypertrophied Tonsils in Correlation with the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases 